You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 9,079,934

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,079,934 protect, and when does it expire?

Patent 9,079,934 protects VILTEPSO and is included in one NDA.

This patent has fifty-two patent family members in twenty countries.

Summary for Patent: 9,079,934

Patent landscape, scope, and claims:

Title:	Antisense nucleic acids
Abstract:	The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene. Also provided is a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency.
Inventor(s):	Watanabe; Naoki (Tsukuba, JP), Satou; Youhei (Tsukuba, JP), Takeda; Shin'ichi (Tokyo, JP), Nagata; Tetsuya (Tokyo, JP)
Assignee:	NIPPON SHINYAKU CO., LTD. (Kyoto-shi, Kyoto, JP) NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY (Kodaira-shi, Tokyo, JP)
Application Number:	13/819,520
Patent Claim Types: see list of patent claims	Use; Composition; Compound;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 9,079,934

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Nippon Shinyaku	VILTEPSO	viltolarsen	SOLUTION;INTRAVENOUS	212154-001	Aug 12, 2020		RX	Yes	Yes	9,079,934	⤷ Subscribe	Y	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,079,934

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2010-196032	Sep 1, 2010

PCT Information
PCT Filed	August 31, 2011	PCT Application Number:	PCT/JP2011/070318
PCT Publication Date:	March 08, 2012	PCT Publication Number:	WO2012/029986

International Family Members for US Patent 9,079,934

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2011296882	⤷ Subscribe
Canada	2809637	⤷ Subscribe
China	103154245	⤷ Subscribe
Cyprus	1117367	⤷ Subscribe
Denmark	2612917	⤷ Subscribe
Denmark	3018211	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.